| HOME | Aspen Virtual Tour | Getting to Aspen | Terrain Map | February 8-12, 2010 |
|
Speakers
|
Claus G. Roehrborn, MD
Dr. Roehrborn’s research interests are in the areas of benign and malignant prostate diseases, including medical and minimally invasive therapies for BPH, and markers for prostate cancer. In addition, he has a background in urological ultrasound and has chaired numerous postgraduate courses and lectured on a variety of topics in ultrasound imaging of the urinary tract. His basic, translational and clinical research has yielded over 250 peer-reviewed publications, more than 30 book chapters, and numerous other contributions to the literature. Aside from being invited to give lectures all over the world, Dr. Roehrborn has chaired or participated in many postgraduate courses and has been visiting professor at leading urological institutions in the United States, Europe, and Asia. Dr. Roehrborn has been the lead researcher for the 1994 Agency for Health Care Policy and Research (AHCPR) BPH Guidelines and has been involved in the American Urological Association (AUA) Guidelines efforts from their inception. He has chaired committees at the WHO-sponsored Consensus Conferences on BPH from 1994 through 2005 and is cochairman of the AUA BPH Guidelines Committee producing an update of the 1994 AHCPR Guidelines in 2003. Dr. Roehrborn serves on the editorial board of many peer-reviewed journals, is associate editor of Urology, and coeditor of the comprehensive and authoritative Textbook of BPH. He is a reviewer for nearly all peer-reviewed journals in the field of urology. At present, Dr. Roehrborn continues to be involved in virtually all aspects of BPH research as well as translational and clinical research in prostatitis and prostate cancer. |
|||||||